(Q46164337)
Statements
Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial (English)
Thomas Spencer
Thomas E Brown
James Holdnack
Keith Saylor
Kory Schuh
Paula T Trzepacz
David W Williams